BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11126380)

  • 41. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
    Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
    World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-dimensional imaging identified the accessory bile duct in a patient with cholangiocarcinoma.
    Miyamoto R; Oshiro Y; Hashimoto S; Kohno K; Fukunaga K; Oda T; Ohkohchi N
    World J Gastroenterol; 2014 Aug; 20(32):11451-5. PubMed ID: 25170235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Extrahepatic cholangiocarcinoma. Diagnostic difficulties and therapeutic options].
    Miño Fugarolas G; Naranjo Rodríguez A
    Gastroenterol Hepatol; 2000 May; 23(5):240-9. PubMed ID: 10902279
    [No Abstract]   [Full Text] [Related]  

  • 45. Simultaneous non-functioning neuroendocrine carcinoma of the pancreas and extra-hepatic cholangiocarcinoma. A case of early diagnosis and favorable post-surgical outcome.
    Maurea S; Corvino A; Imbriaco M; Avitabile G; Mainenti P; Camera L; Galizia G; Salvatore M
    JOP; 2011 May; 12(3):255-8. PubMed ID: 21546703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
    Song DH; Cho IK; Shin DW; Lee JC; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
    Surg Today; 2021 Jun; 51(6):978-985. PubMed ID: 33387024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis of cholangiocarcinoma: a case series and literature review.
    Jabara B; Fargen KM; Beech S; Slakey DR
    J La State Med Soc; 2009; 161(2):89-94. PubMed ID: 19489389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver transplantation for intra- and extrahepatic cholangiocarcinoma.
    Schmeding M; Neumann UP
    Ann Transplant; 2013 Jan; 18():1-8. PubMed ID: 23792495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biliary cholangiocarcinoma].
    Castaing D
    Ann Chir; 1998; 52(2):177-81. PubMed ID: 9752437
    [No Abstract]   [Full Text] [Related]  

  • 50. [Criteria for the resectability of malignant extrahepatic bile duct tumours].
    Kissenkoetter S; Witzigmann H
    Zentralbl Chir; 2012 Feb; 137(1):32-7. PubMed ID: 22344835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholangiocarcinoma.
    Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing strategies in diagnosis and management of hilar cholangiocarcinoma.
    Figueras J; Llado L; Valls C; Serrano T; Ramos E; Fabregat J; Rafecas A; Torras J; Jaurrieta E
    Liver Transpl; 2000 Nov; 6(6):786-94. PubMed ID: 11084070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation and endoscopic palliation of cholangiocarcinoma. Management of cholangiocarcinoma.
    Rumalla A; Baron TH
    Dig Dis; 1999; 17(4):194-200. PubMed ID: 10754358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The current management of hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; Blumgart LH
    Adv Surg; 1999; 33():345-73. PubMed ID: 10572576
    [No Abstract]   [Full Text] [Related]  

  • 55. Management of hilar bile duct carcinoma.
    Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
    Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholangiocarcinoma.
    Ahrendt SA; Nakeeb A; Pitt HA
    Clin Liver Dis; 2001 Feb; 5(1):191-218. PubMed ID: 11218916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current approaches to the diagnosis and treatment of cholangiocarcinoma.
    Reddy SB; Patel T
    Curr Gastroenterol Rep; 2006 Feb; 8(1):30-7. PubMed ID: 16510032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extrahepatic biliary cystadenomas and cystadenocarcinoma. Report of seven cases and review of the literature.
    Davies W; Chow M; Nagorney D
    Ann Surg; 1995 Nov; 222(5):619-25. PubMed ID: 7487208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance in cholangiocellular carcinoma.
    Wirth TC; Vogel A
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):987-999. PubMed ID: 27938792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.